Diffuse Large B-Cell Lymphoma Arising from Cauda Equina: A Rare Case Report and Review of the Literature
Diseases · 02.04.2026 · 14 (4) · 129
DOI: 10.3390/diseases14040129 ↗Kurz gefasst
Fallbericht in der Zeitschrift Diseases, online erschienen am 02.04.2026. Verfasst von Yuma Terada und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Shiga University of Medical Science, Setatsukinowa, Otsu 520-2192, Shiga, Japan. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Malignant lymphoma is the most common hematological malignancy; however, primary central nervous system lymphoma accounts for only a small percentage of non-Hodgkin lymphoma (NHL). Among these, primary cauda equina lymphoma (CEL) is extremely uncommon. Its rarity and atypical clinical presentation often make diagnosis challenging. Case Presentation: An 80-year-old man presented with progressive gait disturbance, lower-extremity weakness, and numbness. MRI revealed diffuse swelling and homogeneous gadolinium enhancement of the cauda equina at T12–L1; additionally, CSF cytology identified malignant lymphocytes. Open biopsy confirmed a diagnosis of diffuse large B-cell lymphoma. At diagnosis, the patient was classified as Ann Arbor stage IV, and the clinical parameters corresponded to a high-risk International Prognostic Index (IPI) category. The patient received five courses of immunochemotherapy with rituximab, methotrexate, vincristine, and procarbazine (R-MPV), resulting in marked radiological improvement and functional recovery, achieving a complete response. However, consolidation therapy was discontinued as the patient did not wish to continue. Unfortunately, intracranial relapse occurred four months later, and the patient ultimately succumbed to infectious complications. Only 29 cases of primary CEL have been reported. For all cases, a biopsy with histopathological examination is required for a definitive diagnosis. Currently, combined chemotherapy and radiotherapy are considered the standard treatment. This case was diagnosed through nerve biopsy with cauda equina at T12 to L1 levels, and immunochemotherapy successfully reduced the lesion while improving lower extremity function.
Conclusions
Despite the considerable burden on patients, nerve biopsy is necessary for primary CEL to obtain a diagnosis and an early therapeutic approach for both neurological and vital prognoses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Shiga University of Medical Science, Setatsukinowa, Otsu 520-2192, Shiga, Japan.
- Department of Orthopedic Surgery, Ohmihachiman Community Medical Center, 1379 Tsuchida, Ohmihachiman 523-0082, Shiga, Japan.
- Department of Spine and Joint Reconstruction, Shiga University of Medical Science, Setatsukinowa, Otsu 520-2192, Shiga, Japan.
- Department of Rehabilitation Medicine, Shiga University of Medical Science, Setatsukinowa, Otsu 520-2192, Shiga, Japan.
ORCID-Profile: Takafumi Yayama, Tomohiro Mimura, Kosuke Kumagai
Zitieren
APA
Terada, Y., Yayama, T., Nakamura, A., Mori, K., Kodama, N., Mimura, T., Ando, K., Kumagai, K., Takemura, Y., & Imai, S. (2026). Diffuse Large B-Cell Lymphoma Arising from Cauda Equina: A Rare Case Report and Review of the Literature. Diseases, 14(4), 129. https://doi.org/10.3390/diseases14040129
Vancouver
Terada Y, Yayama T, Nakamura A, Mori K, Kodama N, Mimura T, et al. Diffuse Large B-Cell Lymphoma Arising from Cauda Equina: A Rare Case Report and Review of the Literature. Diseases. 2026;14(4):129. doi:10.3390/diseases14040129
BibTeX
@article{Terada2026,
author = {Terada, Yuma and Yayama, Takafumi and Nakamura, Akira and Mori, Kanji and Kodama, Narihito and Mimura, Tomohiro and Ando, Kosei and Kumagai, Kosuke and Takemura, Yoshinori and Imai, Shinji},
title = {Diffuse Large B-Cell Lymphoma Arising from Cauda Equina: A Rare Case Report and Review of the Literature},
journal = {Diseases},
year = {2026},
volume = {14},
number = {4},
pages = {129},
doi = {10.3390/diseases14040129}
}
EUVIMED